2025 · Analytical and Bioanalytical Chemistry · paywalled
LC-HRMS screening for 11 classes of prohibited substances in dried urine spots for doping control
Mazzarino et al.
The finding, in our words
A multi-targeted procedure covered 237 prohibited substances across 11 WADA classes in dried urine spots, with environmental-stability testing for refrigeration-free transport.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
The authors found that a single microdose of recombinant EPO was detectable up to 72 hours using ITP and CP methods, though the Tasso microsampling device showed lower sensitivity than Mitra and Capitainer. Additionally, isotope ratio mass spectrometry successfully detected testosterone micro-dosing in all analysed samples, supported by serum testosterone levels.
This review highlights that microsampling techniques such as dried blood spots and volumetric absorptive microsampling offer superior alternatives to traditional sampling for the mass spectrometry detection of prohibited substances in anti-doping analysis. It provides guidance on selecting appropriate analytical methods and sample pretreatment strategies to ensure sensitive detection and reliable storage conditions.
This study compared four dried blood spot devices for glucocorticoid detection, finding that the Mitra VAMS device offered the best combination of analytical recovery and user usability, whilst the HemaXis DB10 showed the least bias compared to whole blood.
The study compared five microsampling devices, including Mitra tips and Tasso-M20, for detecting 27 steroid esters in dried blood by LC-MS/MS, and found that methanol extraction with Girard's reagent P or T provided the best screening sensitivity with detection limits of 0.05 to 1.0 ng/mL, while methoxyamine derivatization was recommended for confirming boldenone and certain testosterone esters. The Tasso-M20 device produced chromatographic interference with methanol extraction that was only partially resolved by using mixed solvents, at the cost of lower recoveries.
Researchers validated a UHPLC-MS/MS assay for citrinin in capillary blood collected with Neoteryx Mitra VAMS devices, plus feces and urine, achieving quantification limits of 0.05 ng/mL. The study derived human toxicokinetic parameters from 48-hour sample collection after a single oral dose, demonstrating that microsampling enables robust population-level exposure assessment for mycotoxins.